MedTrace Logo

Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

NCT05411523 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-02-02

No results posted yet for this study

Summary

This study examines how spinal cord stimulation (SCS) affects pain level and quality of life in patients experiencing chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a nerve problem and one of the potential side effects of chemotherapy that causes pain, numbness, tingling, swelling, or muscle weakness in different parts of the body. CIPN usually begins in the hands or feet and gets worse over time. SCS is a type of therapy that has proven to be effective in treating numerous non-malignant pain disorders including failed back surgery syndrome, refractory angina, limb ischemia, complex regional pain syndrome, and diabetic peripheral neuropathy. SCS may also be useful in patients with CIPN. This study evaluates how SCS affects pain and quality of life in patients undergoing spinal cord stimulation for CIPN.

Conditions

  • Chemotherapy-Induced Peripheral Neuropathy
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm

Interventions

OTHER

Quality-of-Life Assessment

Complete quality of life assessment

OTHER

Questionnaire Administration

Complete questionnaires

PROCEDURE

Spinal Cord Stimulation

Receive spinal cord stimulation therapy

Sponsors & Collaborators

Principal Investigators

  • Ryan S. D'Souza, MD · Mayo Clinic in Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-14
Primary Completion
2027-04-15
Completion
2027-04-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05411523 on ClinicalTrials.gov